Ladenburg Thalmann Downgrades Novavax (NVAX) to Neutral
- Wall Street set to open slightly lower
- U.S. economy less sluggish in second quarter; companies investing more
- Pepsi (PEP) Tops Q3 EPS by 8c
- After Near-Term Outperformance, Barclays Sees Apple (AAPL) Shares Flat from Here
- Pre-Open Stock Movers 09/29: (AEGR) (ARWR) (EBAY) Higher; (ITCI) (ADHD) (FIT) Lower (more...)
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Ladenburg Thalmann downgraded Novavax (NASDAQ: NVAX) from Buy to Neutral and removed its price target (prior $14.15).
Shares of Novavax closed at $8.34 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Stifel Downgrades Targa Resources (TRGP) to Hold
- UPDATE: Brean Capital Downgrades Nike (NKE) to Hold
- UBS Cuts AT&T (T) to Neutral on Lower EPS Estimates
Create E-mail Alert Related CategoriesDowngrades
Related EntitiesLadenburg Thalmann Financial Services
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!